(Q82917720)
Statements
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis (English)
Robert Bissonnette
Catherine Maari
Yihong Yao
Gabriel Robbie
Wendy I White
Chenxiong Le
Barbara White